In June of 2021, retired nurse Linda Leaming, 70, of LaVerne, was admitted to Cedars-Sinai after suffering a stroke. She was delirious and refusing to eat and drink, and her husband, Rich Leaming, struggled with decisions about her care. Neuropalliative specialist Jessica Besbris, MD, director of Neuropalliative Care and the Neurology Supportive Care Medicine Program at Cedars-Sinai, came to his aid.
This tipsheet highlights the latest medical discoveries and faculty news at Cedars-Sinai. Links to full news releases are included with each item.
Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.
Patients who lose a part of their jaw—whether from injury, infection, disease, or as a side effect of cancer treatment—can have the missing jawbone replaced through reconstruction. But most are left with a life-altering dilemma: Their new jaw is missing its teeth. That isn’t the case, however, for those treated by Cedars-Sinai’s “jaw-in-a-day” team.
An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. The findings, which may help prevent death through early detection of one of the most challenging cancers to treat, are published in the journal Cancer Biomarkers.
To commemorate a new art exhibit at Cedars-Sinai, Robert C. Davidson, Jr., vice chair of the Smithsonian Art Museum, will lead an April 27 virtual panel discussion called Open Doors: A Conversation on the Healing Power of Diversity in Art.
The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.
This Donate Life Month, the Nettleton and Conklin families are celebrating nearly 16 years of being family.
Using advanced techniques for imaging the brain and eyes, along with new biomarkers, researchers in the Department of Neurology at Cedars-Sinai are working to present a clearer picture of multiple sclerosis (MS). Their work could lead to improved diagnosis and treatment of the disease, in which the body’s immune system attacks the brain, spinal cord and optic nerves.
Pregnant women continue to have reservations about getting vaccinated against COVID-19 despite research indicating the safety of the vaccines and the protection they may offer their unborn children.
Like many collegiate athletes, Dahlia Fink, 18, was introduced to sports at a young age.
Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm disorders, according to a new study from investigators in the Smidt Heart Institute at Cedars-Sinai.
Physician-scientists from the Smidt Heart Institute at Cedars-Sinai are working to identify genetic risk factors for cardiomyopathy—a collection of conditions that reduce the heart’s ability to pump blood to the rest of the body—and how inherited forms of the condition can be detected at earlier stages.
Throughout the month of April—Donate Life Month—experts from Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute are available for interviews on issues related to transplantation, immunology and organ donation.
Cedars-Sinai Marina del Rey Hospital has received Primary Stroke Center designation from the Joint Commission—a nonprofit accrediting body for healthcare organizations and programs—and the American Stroke Association. The designation certifies the hospital’s readiness to provide evaluation and emergency care for stroke patients beyond what is available at the average hospital.
Every Thursday, a panel of clinicians from Cedars-Sinai gathers on a video call to spend a full hour talking about a single patient. Each week, the patient is different, but all have one thing in common: No doctor has been able to figure out exactly what ails them.
A new drug shows promise in providing relief to hypertrophic cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.
The Los Angeles Barbershop Blood Pressure Study is delivering cutting-edge insights more than four years after the study results were published in The New England Journal of Medicine.
Michelle Kittleson, MD, PhD, Director of Post-Graduate Education in Heart Failure and Transplantation and Director of Heart Failure Research in the Smidt Heart Institute, Can Discuss New Clinical Guidance
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
